MedTrace Logo

Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients

NCT04087993 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2024-08-28

No results posted yet for this study

Summary

Patients with IDA and for whom fast replenishment of iron stores is necessary, e.g. if its not appropriated to postpone surgery, will be identified within 28 to 42 days before surgery. Patients will be randomised to receive either Polyglucoferron intravenously (i.v.), Ferric Carboxymaltose i.v. or oral iron substitution with Ferrous sulfate.

Conditions

Interventions

DRUG

Polyglucoferron

intravenous administration

DRUG

Ferric carboxymaltose

intravenous administration

DRUG

Ferrous Sulfate

oral administration

Sponsors & Collaborators

  • University Hospital Frankfurt, Department of Anaesthesiology

    collaborator UNKNOWN

  • IRON4U

    collaborator UNKNOWN

  • University Hospital Frankfurt Institute for Biostatistics & Mathematical Modelling

    collaborator UNKNOWN

  • Dr. Frank Behrens

    lead OTHER

Principal Investigators

  • Kai Zacharowski, Prof. MD · University Hospital of Goethe-University Frankfurt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-15
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04087993 on ClinicalTrials.gov